Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice
Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice
复制标题
胆囊收缩素-8 对甲基苯丙胺诱导的小鼠行为改变和多巴胺能神经变性的保护作用
DOI:
10.1016/j.bbr.2015.01.028
复制
发表时间:
2015-04-15
影响因子:
2.7
通讯作者:
Cong, Bin
中科院分区:
文献类型:
--
作者:
Gou, Hongyan;Wen, Di;Cong, Bin
We investigated whether pretreatment with the neuropeptide cholecystokinin-8 affected methamphetamine (METH)-induced behavioral changes and dopaminergic neurodegeneration in male C57/BL6 mice. CCK-8 pretreatment alone had no effect on locomotion and stereotypic behavior and could not induce behavioral sensitization; however, it attenuated, in a dose-dependent manner, hyperlocomotion and behavioral sensitization induced by a low dose of METH (1 mg/kg). CCK-8 attenuated METH-induced stereotypic behavior at a dose of 3 mg/kg but not at 10 mg/kg. CCK-8 pretreatment attenuated METH (10 mg/kg)-induced hyperthermia, the decrease of tyrosine hydroxylase (TH) and dopamine transporter (DAT) in the striatum, and TH in the substantia nigra. CCK-8 alone had no effect on rectal temperature, TH and DAT expression in the nigrostriatal region. In conclusion, our study demonstrated that pretreatment with CCK-8 inhibited changes typically induced by repeated exposure to METH, such as hyperlocomotion, behavioral sensitization, stereotypic behavior, and dopaminergic neurotoxicity. These findings make CCK-8 a potential therapeutic agent for the treatment of multiple symptoms associated with METH abuse. (C) 2015 Elsevier B.V. All rights reserved.